Children are not small adults, and a device scaled down from an adult product is usually the wrong device. A child's airway is proportionally narrower and softer, skin is thinner and more permeable, body mass may be one twentieth of an adult's, bones remodel and grow, and the patient may be unable to report pain or hold still. The person operating the device is frequently not the patient at all but an exhausted parent at two in the morning.

The FDA has identified pediatric devices as an underserved area, which cuts both ways. There is real unmet need and less competition, but also thinner predicate history, harder recruitment, and a smaller market to amortize the same regulatory cost.

The FDA's pediatric age groups drive your claims

FDA guidance divides the pediatric population into groups that behave very differently from an engineering standpoint:

  • Neonate: birth to one month
  • Infant: one month to two years
  • Child: two to twelve years
  • Adolescent: twelve to twenty-one years

Your labeling must name the groups the device is indicated for, and every group has to be supported. A device covering neonates through adolescents is a far larger validation exercise than one indicated for children over five, so narrowing the claim for a first release is a legitimate strategy.

Two program-level items matter early. Submissions for devices intended to treat or diagnose a condition that occurs in children must include readily available pediatric subpopulation information, even when the device is not indicated for children. And the Humanitarian Device Exemption pathway carries a pediatric provision permitting profit on devices for small patient populations, which can make an otherwise unviable rare-disease device work commercially. Both sit alongside the routes in our overview of the FDA approval process for medical devices.

Anatomy and physiology change the engineering

Start from real pediatric anthropometric data rather than scaling an adult model by a percentage. Children's proportions differ, not just their size: head circumference relative to body, hand span relative to grip strength, and torso length relative to limb length all shift with age. Our article on anthropometry in product design covers where usable data sets come from.

Practical consequences show up everywhere:

  • Forces and pressures. A cuff pressure, clamp force, or adhesive peel strength that is unremarkable on an adult forearm can bruise or tear neonatal skin. Adhesives must be selected for gentle removal, not maximum hold.
  • Thermal limits. Surface temperature limits under IEC 60601-1 assume a patient who can move away from a hot surface. A sedated infant cannot.
  • Dead space and flow. In respiratory and fluid-handling devices, internal volume that is negligible for an adult can be a meaningful fraction of a child's tidal or circulating volume.
  • Growth. A long-wear device must accommodate a patient who will be substantially larger in a year, so adjustability and staged sizing become part of the architecture.

Biocompatibility with a much smaller body

ISO 10993 evaluation is not scale-free. Extractables and leachables are assessed against exposure per unit of body weight, so a material with an acceptable margin in a 155-pound adult may be marginal in a 7-pound neonate. Toxicological risk assessments must state the body-weight assumption explicitly and use the worst case for the youngest claimed group.

Contact duration also tends to be longer, because devices are often worn continuously through a hospital stay, which can push a device from limited contact into prolonged or permanent and trigger additional endpoints. Our guide to ISO 10993 biocompatibility testing explains the contact category matrix.

Where consumer product safety rules overlap

If the device is used at home and looks anything like a consumer article, you may face two regulators rather than one. Products designed or intended primarily for children twelve and under can fall under CPSC jurisdiction and the Consumer Product Safety Improvement Act, which brings total lead content limits, phthalate restrictions, third-party testing by a CPSC-accepted lab, tracking labels, and a Children's Product Certificate. The full picture is in our article on children's product development and CPSIA requirements.

Whether a given pediatric medical device is exempt is a legal question that depends on the product and how it is marketed, and it deserves a real answer early. The design consequences are the same either way and cheap to adopt:

  • No detachable small parts that fit inside a small-parts test cylinder.
  • Cords, tubing, and straps short enough to avoid a strangulation path, or fitted with a breakaway.
  • Battery compartments secured with a captive screw or two-action latch. Coin cells are a documented ingestion hazard and warrant the strictest closure you can design.
  • No accessible sharp edges or points, and no pinch or finger-trap gaps.
  • Materials free of lead and restricted phthalates, with supplier documentation on file.

Human factors with two users at once

Pediatric devices almost always have a caregiver as the operator and a child as the patient, and sometimes a third user in a clinician. IEC 62366 usability engineering therefore has to be run against multiple user profiles, and the use-related risk analysis has to consider a scenario adult devices rarely face: the patient actively working against the device. Children pull off sensors, chew on tubing, press buttons out of curiosity, and hide symptoms because they do not want another procedure.

Design responses that earn their keep include tamper-resistant controls a caregiver can still operate one-handed, alarms that distinguish a genuine clinical event from a dislodged sensor, physical keying that makes a wrong connection impossible, and instructions written at a reading level a stressed non-clinician can follow. Validate with representative caregivers, not engineers, in a simulated home or bedside environment. Our overview of usability engineering for medical devices covers the structure the FDA expects. Appearance matters too: a less clinical form, softer color, and quieter alarms reduce distress and improve compliance, which is a clinical outcome rather than styling.

Clinical evidence and recruitment

Pediatric clinical work is slower and more constrained. Review boards apply additional protections for children, consent involves parental permission plus the child's assent where age-appropriate, and recruitment pools are small. Where a device is a reasonable extension of an adult product, leveraging adult data plus bench and simulated-use evidence is often the practical route, and it should be raised in a pre-submission meeting rather than guessed at. Our article on clinical trials for medical devices covers when an IDE study becomes unavoidable.

Projects House develops pediatric medical devices from concept through design controls, human factors validation, and regulatory submission, including the biocompatibility and consumer-safety overlap that catches most first-time teams. Describe your device through our contact form and we will map the pathway.